Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Calcium Supplementation in Postmenopausal Women

ClinicalTrials.gov ID: NCT00172172

Public ClinicalTrials.gov record NCT00172172. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 8:58 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Study to Evaluate the Effects of Calcium Supplementation on the Efficacy and Safety of Recombinant Human Parathyroid Hormone (ALX1-11) in Postmenopausal Women With Osteoporosis (CAP Study)

Study identification

NCT ID
NCT00172172
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Shire
Industry
Enrollment
374 participants

Conditions and interventions

Conditions

Interventions

  • PTH/Calcium Drug
  • PTH/placebo Drug
  • placebo Drug

Drug

Eligibility (public fields only)

Age range
45 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 9, 2004
Primary completion
Mar 10, 2005
Completion
Mar 10, 2005
Last update posted
May 24, 2021

2004 – 2005

United States locations

U.S. sites
17
U.S. states
13
U.S. cities
17
Facility City State ZIP Site status
'Boling Clinical Trials Rancho Cucamonga California 91730
'Radiant Research - Lake Worth Lake Worth Florida 33461
Odyssey Research/Bone Density of North Idaho Coeur d'Alene Idaho 83814
'The University of Chicago Chicago Illinois 60637
'University Hospital & Outpatient Center Indianapolis Indiana 46202
'Bethesda Health Research Center Bethesda Maryland 20817
'Michigan Bone & Mineral Clinic Detroit Michigan 48236
Odyssey Research North Platte Nebraska 69101
Creighton University School of Medicine Omaha Nebraska 68131
'New Mexico Clinical Research and Osteoporosis Center Albuquerque New Mexico 87106
'Odyssey Research Services Bismarck North Dakota 58501
Michael J. Lillestol Fargo North Dakota 58103
'Odyssey Research Services Minot North Dakota 58701
'Radiant Research Wyomissing Pennsylvania 19610
Odyssey Research/Avera United Clinic Aberdeen South Dakota 57401
'Brown Clinic Watertown South Dakota 57201
'Diabetes Center of the Southwest Midland Texas 79705

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00172172, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 24, 2021 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00172172 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →